Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study

PURPOSE: To assess the noninferiority, efficacy, and safety of degarelix in achieving and maintaining testosterone at castrate levels (≤0.5 ng/mL) in Korean patients (CS42) versus non-Asian patients with prostate cancer (PCa). METHODS: A Phase III, open-label, multicenter, single-arm trial was condu...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Prostate Int
Main Authors: You, Dalsan, Chung, Byung Ha, Lee, Sang Eun, Kim, Choung-Soo
Format: Artigo
Sprog:Inglês
Udgivet: Asian Pacific Prostate Society 2015
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494635/
https://ncbi.nlm.nih.gov/pubmed/26157762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prnil.2015.02.005
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker